Skip to content
GB Pharma
  • Who we are
    • Our History
    • Why choose us
  • Rare disease
  • Global coverage
  • clinical and observational research
    • observational studies
    • rwe
    • pass/paes
    • Services
    • International coverage
  • Medical devices
    • Pre-market clinical studies
    • Post-market clinical studies
    • Marketing surveys
    • Regulatory affairs
    • Vigilance and Surveillance
  • PSP & post marketing services
    • Patient support program
    • Marketing survey
  • Regulatory affairs
  • Pharmacovigilance
  • We Share | Blog
  • Contacts
    • Work with us

artecosw

Categories Life at GB Pharma Leave a comment

GB Pharma has obtained the prestigious UNI/PDR 125:2022 certification for gender equality.

20 September 2024 by artecosw

This important milestone demonstrates GB Pharma’s commitment to promoting a fair and inclusive work environment

Categories Blog Leave a comment

COMPLIANCE INSIGHTS | Understanding the Regulatory Landscape: the Impact of MDR 2017/745 on Medical Devices

8 March 202423 February 2024 by artecosw

As the medical device industry continues to evolve, so too do the regulatory frameworks governing these critical products.

Categories Article Leave a comment

RISK MANAGEMENT AND MITIGATION | Navigating the Waters of Pharmacovigilance: The Risks and How to Safeguard Your Drug Development Journey

13 March 202423 February 2024 by artecosw

Choosing the right Contract Research Organization (CRO) for your pharmacovigilance services is a critical decision that can shape the success and safety of your drug development journey.

Categories Article Leave a comment

OBSERVATIONAL STUDIES IN CLINICAL RESEARCH | understanding the role of observational studies in clinical research: a comprehensive overview

13 March 202423 February 2024 by artecosw

Observational studies play a pivotal role in the realm of clinical research, offering valuable insights into real-world healthcare practices, disease patterns, treatment outcomes, and more.

Stefania Fiordaliso
Categories Life at GB Pharma Leave a comment

EXCITING NEWS | GB Pharma Welcomes New Digital Marketing and Commercial Director!

13 March 202415 February 2024 by artecosw

We are thrilled to announce a significant addition to the GB Pharma family as we warmly welcome Stefania Fiordaliso to our team as Digital Marketing and Commercial Director

GB Pharma s.r.l.

Via Cesare Ferreri, 11 – 27100 Pavia – Italy
Tel: +39.0382.530059
E-mail: info@gbpharma.it
Partita IVA: 02183430186

Services

  • Global coverage
  • Clinical research
  • Medical devices
  • Marketing Services
  • Regulatory affairs
  • Pharmacovigilance and Drug Safety

Who we are

  • Who we are
  • Why choose us
  • Contacts
  • Work with us

Policy

  • Ethical code
  • Anti-corruption
  • Privacy and Cookie
  • Privacy information
  • Equal Opportunities
  • UNI/Pdr 125:2020 management system certification for gender equality
  • Whistleblowing


      

Design by GSite Web Agency

© 2025 GB Pharma